SLC5A2 and heart failure: Beyond their glucose-lowering effects, SGLT-2 inhibitors have been shown to have direct benefits in heart failure by reducing blood volume, improving myocardial oxygen supply, and exerting anti-inflammatory and anti-fibrotic effects on the heart [5,6].